Diabetes Metab J.  2024 Jul;48(4):518-530. 10.4093/dmj.2024.0087.

Korean National Burden of Disease: The Importance of Diabetes Management

• Kim CN
• Jung YS
• Kim YE
• Ock M
• Yoon SJ

• KMID: 2558034
• DOI: http://doi.org/10.4093/dmj.2024.0087

Abstract

Diagnosing the current health status and disease burden in a population is crucial for public health interventions. The ability to compare the burden of different diseases through a single measure, such as disability-adjusted life years has become feasible and continues to be produced and updated through the Global Burden of Diseases (GBD) study. However, the disease burden values of the GBD study do not accurately reflect the unique situation in a specific country with various circumstances. In response, the Korean National Burden of Disease (KNBD) study was conducted to estimate the disease burden in Koreans by considering Korea’s cultural context and utilizing the available data sources at the national level. Both studies identified non-communicable diseases, such as diabetes mellitus (DM), as the primary cause of disease burden among Koreans. However, the extent of public health interventions currently being conducted by the central and local governments does not align with the severity of the disease burden. This review suggests that despite the high burden of DM in South Korea, the current policies may not fully address its impact, underscoring the need for expanded chronic disease management programs and a shift towards prevention-focused healthcare paradigms.

Keyword

Diabetes mellitus; Global burden of disease; Public health

Figure

• 

  Fig. 1. An illustration of the concept of disability-adjusted life year. Disease A, B, C, and death mean disease and death occurrence.

• 

  Fig. 2. (A) Top 20 leading causes of burden of diseases in Korea. This figure represents a restructured version of the authors’ research results. Adapted from Jung et al. [78]. (B) Trends of Korean national burden of diabetes mellitus by sex. DALY, disability-adjusted life year; TNI, tubulointerstitial nephritis; UNI, urinary tract infection.

• 

Reference

1. Eyal N, Hurst SA, Murray CJL, Schroeder SA, Wikler D. Measuring the global burden of disease: philosophical dimensions. New York: Oxford University Press;2020. Chapter 17, The uses of burden-of-disease data for priority setting. p. 293–306.

2. Murray CJ, Salomon JA, Mathers C. A critical examination of summary measures of population health. Bull World Health Organ. 2000; 78:981–94.

3. Snyder JD, Merson MH. The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. Bull World Health Organ. 1982; 60:605–13.

4. Murray CJ, Lopez AD. Measuring global health: motivation and evolution of the Global Burden of Disease Study. Lancet. 2017; 390:1460–4.

5. Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press;1996.

6. World Bank. World development report 1993: investing in health. New York: Oxford University Press;1993.

7. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997; 349:1498–504.

8. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997; 349:1436–42.

9. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349:1269–76.

10. Murray CJ, Lopez AD. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study. Lancet. 1997; 349:1347–52.

11. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994; 72:429–45.

12. Cooper RS, Osotimehin B, Kaufman JS, Forrester T. Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? Lancet. 1998; 351:208–10.

13. Nord E. Disability weights in the Global Burden of Disease 2010: unclear meaning and overstatement of international agreement. Health Policy. 2013; 111:99–104.

14. Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ. 1999; 319:1423–5.

15. Anand S, Hanson K. Disability-adjusted life years: a critical review. J Health Econ. 1997; 16:685–702.

16. Begg SJ, Vos T, Barker B, Stanley L, Lopez AD. Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. Med J Aust. 2008; 188:36–40.

17. Naghavi M, Abolhassani F, Pourmalek F, Lakeh M, Jafari N, Vaseghi S, et al. The burden of disease and injury in Iran 2003. Popul Health Metr. 2009; 7:9.

18. Yoon SJ, Bae SC, Lee SI, Chang H, Jo HS, Sung JH, et al. Measuring the burden of disease in Korea. J Korean Med Sci. 2007; 22:518–23.

19. Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis. 2007; 1:e114.

20. Iburg KM, Mikkelsen L, Adair T, Lopez AD. Are cause of death data fit for purpose?: evidence from 20 countries at different levels of socio-economic development. PLoS One. 2020; 15:e0237539.

21. Ellingsen CL, Alfsen GC, Ebbing M, Pedersen AG, Sulo G, Vollset SE, et al. Garbage codes in the Norwegian Cause of Death Registry 1996-2019. BMC Public Health. 2022; 22:1301.

22. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392:1736–88.

23. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392:1789–858.

24. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396:1223–49.

25. Kim YE, Jung YS, Ock M, Yoon SJ. DALY estimation approaches: understanding and using the incidence-based approach and the prevalence-based approach. J Prev Med Public Health. 2022; 55:10–8.

26. Solberg CT, Sorheim P, Muller KE, Gamlund E, Norheim OF, Barra M. The devils in the DALY: prevailing evaluative assumptions. Public Health Ethics. 2020; 13:259–74.

27. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012; 380:2063–6.

28. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396:1204–22.

29. Ock M, Lee JY, Oh IH, Park H, Yoon SJ, Jo MW. Disability weights measurement for 228 causes of disease in the Korean Burden of Disease Study 2012. J Korean Med Sci. 2016; 31(Suppl 2):S129–38.

30. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012; 380:2129–43.

31. Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015; 3:e712–23.

32. He Q, Zhou M, Yin P, Jiang B, Qi J, Liu Y, et al. Can global or national disability weights represent provincial level? BMC Public Health. 2023; 23:461.

33. Ustun TB, Saxena S, Rehm J, Bickenbach J. Are disability weights universal? WHO/NIH Joint Project CAR Study Group. Lancet. 1999; 354:1306.

34. Im D, Mahmudah NA, Yoon SJ, Kim YE, Lee DH, Kim YH, et al. Updating Korean disability weights for causes of disease: adopting an add-on study method. J Prev Med Public Health. 2023; 56:291–302.

35. Kim YE, Jo MW, Park H, Oh IH, Yoon SJ, Pyo J, et al. Updating disability weights for measurement of healthy life expectancy and disability-adjusted life year in Korea. J Korean Med Sci. 2020; 35:e219.

36. Ock M, Ko S, Lee HJ, Jo MW. Review of issues for disability weight studies. Health Policy Manag. 2016; 26:352–8.

37. Mathers CD. History of global burden of disease assessment at the World Health Organization. Arch Public Health. 2020; 78:77.

38. World Health Organization. World health report. Health systems: improving performance. Geneva: WHO;2000. p. 216.

39. World Health Organization. World health report: reducing risks, promoting healthy life. Geneva: WHO;2002. p. 248.

40. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr. 2003; 1:4.

41. Murray CJ, Lopez AD, Black R, Mathers CD, Shibuya K, Ezzati M, et al. Global burden of disease 2005: call for collaborators. Lancet. 2007; 370:109–10.

42. Vollset SE, Goren E, Yuan CW, Cao J, Smith AE, Hsiao T, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. Lancet. 2020; 396:1285–306.

43. Kim E, Yun J, Kim CY, Chung SH, Son SH, Choi YS, et al. Estimates of future population, birth rate, and number of total births and children in South Korea: comparison with past statistics. Perinatology. 2021; 32:166–76.

44. Organisation for Economic Co-operation and Development. Fertility rates. Available from: https://data.oecd.org/pop/fertility-rates.htm (cited 2024 Jun 19).

45. World Bank. Fertility rate, total (births per woman). Available from: https://data.worldbank.org/indicator/SP.DYN.TFRT.IN (cited 2024 Jun 19).

46. GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396:1160–203.

47. Institute of Health Metrics and Evaluation. GBD results. Available from: https://vizhub.healthdata.org/gbd-results (cited 2024 Jun 19).

48. Hong S, Won YJ, Park YR, Jung KW, Kong HJ, Lee ES, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat. 2020; 52:335–50.

49. Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2019. Cancer Res Treat. 2022; 54:330–44.

50. Leipziger D. Korea’s economy volume 30. Washington D.C: Korea Economic Institute of America;2016. Chapter, Lessons from the economic development experience of South Korea. p. 1–5.

51. GBD 2019 South Korea BoD Collaborators. Population health outcomes in South Korea 1990-2019, and projections up to 2040: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2023; 8:e639–50.

52. Go DS, Kim YE, Radnaabaatar M, Jung Y, Jung J, Yoon SJ. Regional differences in years of life lost in Korea from 1997 to 2015. J Korean Med Sci. 2018; 34(Suppl 1):e91.

53. Jo MW, Seo W, Lim SY, Ock M. The trends in health life expectancy in Korea according to age, gender, education level, and subregion: using quality-adjusted life expectancy method. J Korean Med Sci. 2018; 34(Suppl 1):e88.

54. Yoon SJ, Bae SC. Current scope and perspective of burden of disease study based on health related quality of life. J Korean Med Assoc. 2004; 47:600–2.

55. Bae S, Lee S, Yoon S, Yim J, Hong D, Do Y, et al. A study on improvement of health-related quality of life by measurement of disease burden in Korea. Seoul: Ministry of Health and Welfare;2005.

56. Yoon J, Yoon SJ. Quantifying burden of disease to measure population health in Korea. J Korean Med Sci. 2016; 31(Suppl 2):S101–7.

57. Kim YE, Yoon SJ. Measuring the Korean National Burden of Diseases: international comparison and policy implication. Evid Value Healthc. 2017; 3:138–50.

58. Kim EJ, Yoon SJ, Jo MW, Kim HJ. Measuring the burden of chronic diseases in Korea in 2007. Public Health. 2013; 127:806–13.

59. Lee KS, Park JH. Burden of disease in Korea during 2000-10. J Public Health (Oxf). 2014; 36:225–34.

60. Yoon S, Jo M, Park H, Oh I, Kim B, Kim D, et al. A study on measuring and forecasting the burden of disease in Korea. Seoul: Cardiovascular and Metabolic Diseases Etiology Research Center;2015.

61. Park SY, Kwon I, Oh IH. Burden of disease study and priority setting in Korea: an ethical perspective. J Korean Med Sci. 2016; 31(Suppl 2):S108–13.

62. Lee YH, Yoon SJ, Kim A, Seo H, Ko S. Health performance and challenges in Korea: a review of the global burden of disease study 2013. J Korean Med Sci. 2016; 31(Suppl 2):S114–20.

63. Lee YR, Kim YA, Park SY, Oh CM, Kim YE, Oh IH. Application of a modified garbage code algorithm to estimate cause-specific mortality and years of life lost in Korea. J Korean Med Sci. 2016; 31(Suppl 2):S121–8.

64. Lee JY, Ock M, Kim SH, Go DS, Kim HJ, Jo MW. Health-adjusted life expectancy (HALE) in Korea: 2005-2011. J Korean Med Sci. 2016; 31(Suppl 2):S139–45.

65. Yoon J, Oh IH, Seo H, Kim EJ, Gong YH, Ock M, et al. Disability-adjusted life years for 313 diseases and injuries: the 2012 Korean Burden of Disease Study. J Korean Med Sci. 2016; 31(Suppl 2):S146–57.

66. Yoon J, Seo H, Oh IH, Yoon SJ. The non-communicable disease burden in Korea: findings from the 2012 Korean Burden of Disease Study. J Korean Med Sci. 2016; 31(Suppl 2):S158–67.

67. Gong YH, Yoon SJ, Jo MW, Kim A, Kim YA, Yoon J, et al. The burden of cancer in Korea during 2012: findings from a prevalence-based approach. J Korean Med Sci. 2016; 31(Suppl 2):S168–77.

68. Lee YR, Moon K, Kim YA, Park SY, Oh CM, Lee KS, et al. Disability-adjusted life years for communicable disease in the Korean Burden of Disease Study 2012. J Korean Med Sci. 2016; 31(Suppl 2):S178–83.

69. Kim SH, Lee HJ, Ock M, Go DS, Kim HJ, Lee JY, et al. Disability-adjusted life years for maternal, neonatal, and nutritional disorders in Korea. J Korean Med Sci. 2016; 31(Suppl 2):S184–90.

70. Lim D, Lee WK, Park H. Disability-adjusted life years (DALYs) for mental and substance use disorders in the Korean Burden of Disease Study 2012. J Korean Med Sci. 2016; 31(Suppl 2):S191–9.

71. Lee WK, Lim D, Park H. Disability-adjusted life years (DALYs) for injuries using death certificates and hospital discharge survey by the Korean Burden of Disease Study 2012. J Korean Med Sci. 2016; 31(Suppl 2):S200–7.

72. Park B, Ock M, Jo MW, Lee HA, Lee EK, Park B, et al. Health gap for multimorbidity: comparison of models combining uniconditional health gap. Qual Life Res. 2020; 29:2475–83.

73. Jung YS, Kim YE, Park H, Oh IH, Jo MW, Ock M, et al. Measuring the burden of disease in Korea, 2008-2018. J Prev Med Public Health. 2021; 54:293–300.

74. Jung YS, Kim YE, Ock M, Yoon SJ. Trends in healthy life expectancy (HALE) and disparities by income and region in Korea (2008-2020): analysis of a nationwide claims database. J Korean Med Sci. 2024; 39:e46.

75. Kim YE, Park H, Jo MW, Oh IH, Go DS, Jung J, et al. Trends and patterns of burden of disease and injuries in Korea using disability-adjusted life years. J Korean Med Sci. 2019; 34(Suppl 1):e75.

76. Jung YS, Yoon SJ. Trends and patterns of cancer burdens by region and income level in Korea: a national representative big data analysis. Cancer Res Treat. 2023; 55:408–18.

77. Sullivan DF. A single index of mortality and morbidity. HSMHA Health Rep. 1971; 86:347–54.

78. Jung YS, Kim YE, Ock M, Yoon SJ. Measuring the burden of disease in Korea using disability-adjusted life years (2008-2020). J Korean Med Sci. 2024; 39:e67.

79. Heneweer H, Picavet HS, Staes F, Kiers H, Vanhees L. Physical fitness, rather than self-reported physical activities, is more strongly associated with low back pain: evidence from a working population. Eur Spine J. 2012; 21:1265–72.

80. LaMonte MJ, Blair SN, Church TS. Physical activity and diabetes prevention. J Appl Physiol (1985). 2005; 99:1205–13.

81. Li X, Feng X, Sun X, Hou N, Han F, Liu Y. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2019. Front Aging Neurosci. 2022; 14:937486.

82. Health Insurance Review and Assessment Service. Analysis of the treatment status for depression and anxiety disorders over the last five years (2017-2021). Available from: https://url.kr/lz4a5t (cited 2024 Jun 19).

83. Morrow RH, Hyder AA, Murray CJ, Lopez AD. Measuring the burden of disease. Lancet. 1998; 352:1859–61.

84. Go DS, Kim YE, Paik JW, Roh S, Yoon SJ. A comparison of disease burden and the government budget for mental health in Korea. J Ment Health. 2022; 31:471–8.

85. Smith N, Mitton C, Davidson A, Williams I. A politics of priority setting: ideas, interests and institutions in healthcare resource allocation. Public Policy Adm. 2014; 29:331–47.

86. Choi HH, Choi G, Yoon H, Ha KH, Kim DJ. Rising incidence of diabetes in young adults in South Korea: a national cohort study. Diabetes Metab J. 2022; 46:803–7.

87. Yang YS, Han K, Sohn TS, Kim NH. Young-onset type 2 diabetes in South Korea: a review of the current status and unmet need. Korean J Intern Med. 2021; 36:1049–58.

88. Hong YH, Chung IH, Han K, Chung S; Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity. Prevalence of type 2 diabetes mellitus among Korean children, adolescents, and adults younger than 30 years: changes from 2002 to 2016. Diabetes Metab J. 2022; 46:297–306.

89. Yang YS, Han BD, Han K, Jung JH, Son JW; Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity. Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019. J Obes Metab Syndr. 2022; 31:169–77.

90. Jung YS, Kim YE, Go DS, Yoon SJ. Projecting the prevalence of obesity in South Korea through 2040: a microsimulation modelling approach. BMJ Open. 2020; 10:e037629.

91. Bae JH, Han KD, Ko SH, Yang YS, Choi JH, Choi KM, et al. Diabetes fact sheet in Korea 2021. Diabetes Metab J. 2022; 46:417–26.

92. Oh SH, Ku H, Park KS. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data. BMC Public Health. 2021; 21:548.

93. Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022; 18:525–39.

94. Song SJ, Han K, Choi KS, Ko SH, Rhee EJ, Park CY, et al. Trends in diabetic retinopathy and related medical practices among type 2 diabetes patients: results from the National Insurance Service Survey 2006-2013. J Diabetes Investig. 2018; 9:173–8.

95. Moon SS, Kim CH, Kang SM, Kim ES, Oh TJ, Yun JS, et al. Status of diabetic neuropathy in Korea: a National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015). Diabetes Metab J. 2021; 45:115–9.

96. Jung CH, Chung JO, Han K, Ko SH, Ko KS, Park JY, et al. Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013). Cardiovasc Diabetol. 2017; 16:1.

97. Nouwen A, Adriaanse MC, van Dam K, Iversen MM, Viechtbauer W, Peyrot M, et al. Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis. Diabet Med. 2019; 36:1562–72.

98. Xue M, Xu W, Ou YN, Cao XP, Tan MS, Tan L, et al. Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019; 55:100944.

99. Ezzati M, Lopez AD, Rodgers A, Murray CJL. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization;2004. Chapter 27, Potential health gains from reducing multiple risk factors. p. 2167–91.

100. Park MK, Park HK, Kim HJ, Kim OJ, Gong MY. Health management experience of residents through participation in the community based hypertension and diabetes registry program. J Korean Acad Community Health Nurs. 2021; 32:518–28.

101. Yun SK. Current status and problems of national diabetes care. J Korean Diabetes. 2020; 21:173–8.

102. Ministry of Health and Welfare. An overview of Ministry of Health and Welfare budget and fund operation plan in 2024. Available from: https://url.kr/koqp6w (cited 2024 Jun 19).

103. Song E, Kim YE, Ji S. Impact of a primary health care chronic diseases management pilot program. Korean J Med. 2021; 96:7–12.

104. Ganz M. Prevention of type 2 diabetes. Chichester: John Wiley & Sons;2005. Chapter 9, A paradigm shift is needed in the primary prevention of type 2 diabetes. p. 153–68.

105. Pryor K, Volpp K. Deployment of preventive interventions: time for a paradigm shift. N Engl J Med. 2018; 378:1761–3.